Imaging Elevated Brain Arachidonic Acid Signaling in Unanesthetized Serotonin Transporter (5-HTT)-Deficient Mice
Open Access
- 14 January 2009
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 34 (7) , 1695-1709
- https://doi.org/10.1038/npp.2008.227
Abstract
Certain polymorphisms reduce serotonin (5-HT) reuptake transporter (5-HTT) function and increase susceptibility to psychiatric disorders. Heterozygous (5-HTT+/−)-deficient mice, models for humans with these polymorphisms, have elevated brain 5-HT concentrations and behavioral abnormalities. As postsynaptic 5-HT2A/2C receptors are coupled to cytosolic phospholipase A2 (cPLA2), which releases arachidonic acid (AA) from membrane phospholipid, 5-HTT-deficient mice may have altered brain AA signaling and metabolism. To test this hypothesis, signaling was imaged as an AA incorporation coefficient k* in unanesthetized homozygous knockout (5-HTT−/−), 5-HTT+/− and wild-type (5-HTT+/+), mice following saline (baseline) or 1.5 mg/kg s.c. DOI, a partial 5-HT2A/2C receptor agonist. Enzyme activities, metabolite concentrations, and head-twitch responses to DOI were also measured. Baseline k* was widely elevated by 20–70% in brains of 5-HTT+/− and 5-HTT−/− compared to 5-HTT+/+ mice. DOI increased k* in 5-HTT+/+ mice, but decreased k* in 5-HTT-deficient mice. Brain cPLA2 activity was elevated in 5-HTT-deficient mice; cyclooxygenase activity and prostaglandin E2 and F2α and thromboxane B2 concentrations were reduced. Head-twitch responses to DOI, although robust in 5-HTT+/+ and 5-HTT+/− mice, were markedly fewer in 5-HTT−/− mice. Pretreatment with para-chlorophenylalanine, a 5-HT synthesis inhibitor, restored head twitches in 5-HTT−/− mice to levels in 5-HTT+/+ mice. We propose that increased baseline values of k* in 5-HTT-deficient mice reflect tonic cPLA2 stimulation through 5-HT2A/2C receptors occupied by excess 5-HT, and that reduced k* and head-twitch responses to DOI reflected displacement of receptor-bound 5-HT by DOI with a lower affinity. Increased baseline AA signaling in humans having polymorphisms with reduced 5-HTT function might be identified using positron emission tomography.Keywords
This publication has 72 references indexed in Scilit:
- How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systemsNeuropharmacology, 2008
- Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient micePsychopharmacology, 2008
- Imaging Neuroinflammation in Alzheimer's Disease with Radiolabeled Arachidonic Acid and PETJournal of Nuclear Medicine, 2008
- Chronic N-methyl-d-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized ratJournal of Lipid Research, 2008
- Chronic Carbamazepine Administration Reduces N-Methyl-D-Aspartate Receptor–Initiated Signaling via Arachidonic Acid in Rat BrainBiological Psychiatry, 2007
- Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse modelsJournal of Neurochemistry, 2007
- Early Life Blockade of 5-Hydroxytryptamine 1A Receptors Normalizes Sleep and Depression-Like Behavior in Adult Knock-Out Mice Lacking the Serotonin TransporterJournal of Neuroscience, 2006
- Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive DisorderAmerican Journal of Human Genetics, 2006
- Brain region‐specific alterations of 5‐HT2A and 5‐HT2C receptors in serotonin transporter knockout miceJournal of Neurochemistry, 2003
- Anxiety and plasma free fatty acids (FFA)Life Sciences, 1969